Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Guidances | Drugs

Guidances | Drugs

                        Product-Specific Guidances for Generic Drug Development
          Guidance Snapshot Pilot Home
          Drugs
          Guidance, Compliance, & Regulatory Information
          Guidances | Drugs
          Instructions for Submitting Drafts of Proposed Guidance Documents ElectronicallyGuidances | Drugs Instructions for Submitting Drafts of Proposed Guidance Documents Electronically
  
  	
    Share
    Post
    Linkedin

    Email
    PrintUnder FDA’s good guidance practices regulations at 21 CFR 10.115(f)(3), external parties can submit drafts of proposed guidance documents for FDA to consider. All proposed draft guidance documents should be marked “Guidance Document Submission” and be submitted either in paper to the address found on the Dockets Management page or electronically.
Submitting drafts of proposed guidance documents electronically requires adapting the "Comment" function on www.regulations.gov under the shell docket number that FDA has designated for submitting specific submissions to FDA’s Dockets Management Staff (DMS). To submit a draft proposed guidance document electronically, please follow these instructions:
In your internet browser, go to www.regulations.gov.
    Type **FDA-2013-S-0610** in the "SEARCH for" field. Select "Search" on the blue button to the right or "Enter" key on your keyboard.
    You will be directed to the shell docket titled “Specific Electronic Submissions Intended for FDA’s Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions).”
    Select the "Comment Now!" button. Instead of a "comment" you will be submitting your electronic Guidance Document Submission and preferably a cover letter.
    In the comment box, indicate that your Guidance Document Submission and cover letter are attached. Click on the "Choose file" button to upload your Guidance Document Submission file(s). So that you can be provided with a letter that acknowledges receipt of your guidance document submission and provides your unique docket ID number, check the box that states, “I want to provide my contact information,” and enter your Email address. Select a stakeholder Category.
    Your uploaded Guidance Document Submission file(s) will be listed and the information you provided will be displayed.
    Select the "Continue" button to preview and make any edits to your electronic submission.
    Read and check the disclaimer box. You must agree with the disclaimer to submit your Guidance Document Submission.
    Select the "Submit Comment" button. This action will submit your Guidance Document Submission to the system.
    You will receive a receipt with a tracking number automatically generated by www.regulations.gov. The Guidance Document Submission will be assigned a unique docket ID (***FDA-YYYY-D-XXXX***) and you will receive a letter acknowledging its receipt.  Information about your Guidance Document Submission will be publicly viewable only in that assigned docket ID and not in the shell docket for specific electronic submissions.  If you do not receive your assigned docket ID within three business days, you may call DMS at 240-402-7500.

                                                                                  Content current as of:
      09/20/2018Guidances | Drugs

          
                        Product-Specific Guidances for Generic Drug Development
          Guidance Snapshot Pilot
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop